Vulnerable Point in Solid Organ Cancers Discovered for CAR-T Therapy
Scientists have identified a vulnerable point in solid organ cancers, such as kidney, pancreatic, and ovarian cancer, that can be targeted with CAR-T cells, with human trials planned after successful therapy in mice.
Coverage Timeline
Read at source (3 outlets)
A living drug manages to eliminate tumors in mice with pancreatic, ovarian and kidney cancer
The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of leukemias and lymphomas
By Manuel Ansede
Read full article →Las defensas entrenadas atacan el "castillo" de los tumores sólidos: las terapias CAR-T encuentran debilidades en el riñón, ovario y páncreas
Una nueva terapia de ingeniería consigue "burlar" a las células cancerígenas en los órganos para eliminarlas. "Las CAR-T son células que se multiplican dentro del paciente con respuestas duraderas", sostiene el investigador Michel Sadelain Leer
By Pilar Pérez
Read full article →Descubren un punto vulnerable en cánceres de órganos sólidos para atacarlos con células CAR-T
Los científicos planean ensayos en pacientes tras el éxito de la terapia en ratones con cáncer de riñón, páncreas y ovario
By Josep Corbella Domenech
Read full article →
